When the Recon finally goes on sale, it’ll give customers an EV that’s truly capable off-road. It’ll also help the company play catch up with competitors who are already stealing market ...

The FDA has approved Johnson & Johnson’s (J&J) Spravato (esketamine) CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD). According to ...

Moderna will receive some $590 million from the U.S. government to develop messenger RNA vaccines for influenza strains, such as H5N1, that are seen as potential pandemic risks. Announced Friday as ...

But Datroway’s results come up short compared with Enhertu. The Citeline report also noted one treatment-related death in the Datroway trial. Given that patients with advanced breast cancer have ...

Enhertu. The approval is the first in the U.S. for Datroway, which got clearance in Japan last month. Astra and Daiichi withdrew an application in the European Union for the drug to treat a type ...

Jeep's new inbound all-electric Recon off-roader could be ready to enter production by February, according to a recent report. MoparInsiders reports that Stellantis bumped up the Recon EV's ...

A new Ghost Recon game has leaked online and it’s apparently going to release soon. Tom Clancy’s Ghost Recon began back on November 13, 2001 with the release of a game of the same name on PC ...

We may earn a commission from links on this page. The Recon was unveiled back in 2022 when it was meant to herald a new electric era for the historic American brand. The EV was heavily inspired by ...

It's been more than two years Jeep first floated its Recon nameplate past us, teasing it as aa boxy, electric SUV with an off-road focus. Now, its time to shine as a production model is nearly ...

The rugged new electric SUV will be here before you know it. Jeep is fast-tracking Recon EV production as it prepares for an upcoming launch. Here’s what to expect from Jeep’s new electric SUV ...

Enhertu is already approved as a third-line therapy for HER2-positive metastatic breast cancer and a second-line therapy for HER2-positive metastatic gastric cancer, and recent data from the ...

Enhertu is already approved as a third-line therapy for HER2-positive breast cancer, but moving the drug up the treatment pathway could make it an option for a larger group of patients and ...